Study of ISM5939 in Patients With Advanced and/or Metastatic Solid Tumors

NCT06724042 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

159

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor
Metastatic Solid Tumor
Advanced and/or Metastatic Solid Tumors

Interventions

DRUG: ISM5939
DRUG: Cisplatin
DRUG: Docetaxel
DRUG: Pembrolizumab

Sponsor

InSilico Medicine Hong Kong Limited